Bootstrap statistics of ECASS II data: Just another post hoc analysis of a negative stroke trial?

被引:17
作者
Stingele, R
Bluhmki, E
Hacke, W
机构
[1] Univ Heidelberg, Dept Neurol, D-69120 Heidelberg, Germany
[2] Boehringer Ingelheim KG, Clin Res & Stat, D-6507 Ingelheim, Germany
关键词
ECASS II; bootstrap statistics; thrombolysis; acute ischaemic stroke;
D O I
10.1159/000047608
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The results of the Second European-Australasian Acute Stroke Study (ECASS II) were negative with respect to the primary endpoint. This post hoc analysis of ECASS II data was designed to make the least number of a priori assumptions. This is accomplished by a bootstrap-based hypothesis test on a non-parametric test statistic. No assumptions are made on shape or variance of population distributions and the method does not suffer from the disadvantages of dichotomization. By reducing the number of a priori assumptions, the possibilities to modify the test result by adjusting the test procedure are minimized. Results: If rt-PA does not improve the outcome (null hypothesis), the probability of observing a difference of modified ranking scale equal or larger than the one observed in ECASS II is 0.047. We therefore rejected the null hypothesis. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:30 / 33
页数:4
相关论文
共 5 条
[1]   Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) [J].
Hacke, W ;
Kaste, M ;
Fieschi, C ;
von Kummer, R ;
Davalos, A ;
Meier, D ;
Larrue, V ;
Bluhmki, E ;
Davis, S ;
Donnan, G ;
Schneider, D ;
Diez-Tejedor, E ;
Trouillas, P .
LANCET, 1998, 352 (9136) :1245-1251
[2]  
HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017
[3]   Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set - Post hoc analysis of ECASS I [J].
Hacke, W ;
Bluhmki, E ;
Steiner, T ;
Tatlisumak, T ;
Mahagne, MH ;
Sacchetti, ML ;
Meier, D .
STROKE, 1998, 29 (10) :2073-2075
[4]   TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE [J].
MARLER, JR ;
BROTT, T ;
BRODERICK, J ;
KOTHARI, R ;
ODONOGHUE, M ;
BARSAN, W ;
TOMSICK, T ;
SPILKER, J ;
MILLER, R ;
SAUERBECK, L ;
JARRELL, J ;
KELLY, J ;
PERKINS, T ;
MCDONALD, T ;
RORICK, M ;
HICKEY, C ;
ARMITAGE, J ;
PERRY, C ;
THALINGER, K ;
RHUDE, R ;
SCHILL, J ;
BECKER, PS ;
HEATH, RS ;
ADAMS, D ;
REED, R ;
KLEI, M ;
HUGHES, S ;
ANTHONY, J ;
BAUDENDISTEL, D ;
ZADICOFF, C ;
RYMER, M ;
BETTINGER, I ;
LAUBINGER, P ;
SCHMERLER, M ;
MEIROSE, G ;
LYDEN, P ;
RAPP, K ;
BABCOCK, T ;
DAUM, P ;
PERSONA, D ;
BRODY, M ;
JACKSON, C ;
LEWIS, S ;
LISS, J ;
MAHDAVI, Z ;
ROTHROCK, J ;
TOM, T ;
ZWEIFLER, R ;
DUNFORD, J ;
ZIVIN, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1581-1587
[5]  
TIBSHIRANI R. J., 1998, MONOGRAPHS STAT APPL, V57